SCHEMBL24413615

SCHEMBL24413615

Cc1ccc(Oc2cc(OC(=O)C(F)(F)S(=O)(=O)O)cc(Oc3ccc(I)cc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.38
HTT P42858 2/20 0.35
MMP13 P45452 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTGS2 P35354 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
AR P10275 1/20 0.33
GFER P55789 1/20 0.33
LMNA P02545 1/20 0.33
MMP2 P08253 3/20 0.33
MMP9 P14780 3/20 0.33
CYP2C9 P11712 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
PTGS1 P23219 1/20 0.32
TBXA2R P21731 1/20 0.32
LPAR1 Q92633 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24413785 0.94 ELANE (0.39) ELANEL3MBTL1MMP2MMP9TBXA2R
SCHEMBL24413616 0.88 MAPT (0.36) ELANEPTGS2MAPTMAPK1LMNA
SCHEMBL24413518 0.87 LMNA (0.35) ELANEHTTMMP13SMN1; SMN2PTGS2
SCHEMBL24413533 0.87 ELANE (0.46) ELANESMN1; SMN2L3MBTL1MMP2MMP9
SCHEMBL24414011 0.85 ELANE (0.41) ELANEHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL24413519 0.83 LMNA (0.32) ELANEHTTMMP13SMN1; SMN2PTGS2
SCHEMBL24414033 0.81 ELANE (0.44) ELANEPTGS2MAPTLMNACYP2C9
SCHEMBL24414017 0.80 KIF11 (0.41) ELANEMMP13MMP2MMP9KMT2A
SCHEMBL24413648 0.79 ELANE (0.40) ELANEPTGS2MAPTLMNACYP2C9
SCHEMBL24414015 0.79 ELANE (0.37) ELANEMAPTMAPK1ARTBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, FGFR1, NHERF1 ELANE 1517/4885HTT 2154/4885MMP13 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.